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Abstract
Zygomycosis is an infection caused by opportunistic fungi of the Zygomycetes class, specifically those from the Mucorales and 
Entomophthorales orders. It is an uncommon disease, mainly restricted to immunocompromised patients. We report a case of a 
73-year-old male patient with a history of fever (39°C) lasting for 1 day, accompanied by shivering, trembling, and intense asthenia. 
The patient was admitted to the intensive care unit with complex partial seizures, and submitted to orotracheal intubation and 
mechanical ventilation under sedation with midazolam. The electroencephalogram showed evidence of non-convulsive status 
epilepticus. There is no fast specific laboratory test that permits confirmation of invasive fungal disease. Unless the physician 
suspects this condition, the disease may progress rapidly while the patient is treated with broad-spectrum antibiotics. Differential 
diagnosis between fungal and bacterial infection is often difficult. The clinical presentation is sometimes atypical, and etiologi-
cal investigation is not always successful. In the present case, the histopathological examination of the biopsy obtained from 
the right temporal lobe indicated the presence of irregular, round, thick-walled fungi forming papillae and elongated structures 
of irregular diameter, with no septa, indicative of zygomycete (Basidiobolus). Treatment with liposomal amphotericin B and 
fluconazole was initiated after diagnosis of meningoencephalitis by zygomycete, with a successful outcome.
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Zygomycetes are opportunistic agents that produce 
infections and cause diseases in situations where the host 
presents some kind of intrinsic immune disorder. Except 
for their opportunistic character, little is known about the 
pathogenesis of zygomycetes, with consequent difficulty 
in planning treatment, leading to the use of broad-spec-
trum and highly nephrotoxic antifungal agents, such as 
amphotericin B. The diseases due to these fungi, which 
belong to the family Mucoraceae, were initially referred 
to as mucormycosis. More recently, these diseases have 
been designated zygomycosis because cases of invasive 
diseases by fungi belonging to other families or even to the 
order Entomophthorales have been described (1). In fact, 
zygomycosis is a broader designation than mucormycosis 
since it is an infection by opportunistic fungi belonging to 
the Zygomycetes class, which in turn is divided into two 
orders: Mucorales and Entomophthorales. These two orders 
are responsible for different types of severe infections. The 
genera rhizopus, absidia, and mucor are the most frequent 
pathological agents within the Zygomycetes class (1,2). 
Zycomycosis has several types of clinical manifestations 
including rhinocerebral, gastrointestinal, pulmonary, and 
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subcutaneous infections, as well as burn wound colonization 
with invasion of blood vessels. The rhinocerebral type is 
the most dramatic, but also the rarest. It usually starts with 
manifestations in the paranasal sinuses because airborne 
spores first enter the body via inhalation (3). 
Immunocompromising states such as hematological 
malignancy, bone marrow or solid organ transplant, neu-
tropenia, diabetes mellitus with or without ketoacidosis, 
treatment with deferoxamine for iron overload, and corti-
costeroids predispose patients to infection. The occurrence 
of zygomycosis in immunocompetent hosts is rare and 
usually related to trauma. Death rates can approach 100% 
depending on the patient’s underlying disease and the form 
of zycomycosis (1,4-6). The main risk factors for fungal infec-
tions in hospitalized patients are the use of broad-spectrum 
antibiotics, chemotherapy, previous colonization, parenteral 
nutrition, surgery, hemodialysis, prolonged therapy with 
corticosteroids, cancer, intravascular catheter, invasive 
mechanical ventilation, neutropenia, HIV infection, diabetes 
mellitus, severe malnutrition, and invasive procedures. Per-
cutaneous skin lesion and spore inhalation are risk factors 
for non-hospitalized immunocompetent patients. This report 
describes a case of meningoencephalitis caused by zygo-
mycetes with a clinical histopathological and mycological 
diagnosis, affecting an immunocompetent patient.
Case report
A 73-year-old male patient from Ribeirão Preto, São 
Paulo, Brazil, was admitted to the Infectious Diseases Unit 
of the University Hospital, Faculty of Medicine of Ribeirão 
Preto, on March 23, 2008, with a history of fever (39°C) 
lasting for 1 day, accompanied by shivering, trembling, and 
intense asthenia. 
Previous history. The patient had been suffering from 
tonic-clonic seizures since 2003 and was taking phenytoin at 
the dose of 200 mg/day. The individual had been diagnosed 
with mitral stenosis, mitral valve prolapse, and systemic 
arterial hypertension. 
Physical examination upon hospital admission revealed 
a patient in good general health, blood pressure = 170/100 
mmHg, heart rate = 80 bpm, temperature = 39°C, and left 
inferior quadrantopsia. Five days after hospital admission, 
the consciousness level worsened (Glasgow coma score = 
11) and the patient presented asymmetry of muscle force 
in the left arm as well as recurrent complex partial seizures. 
Laboratory examinations upon admission to the intensive 
care unit (ICU) revealed: leukocytes = 13,700/mm3, glycemia 
= 112 mg/dL, sodium = 136 mEq/L, potassium = 2.8 mEq/L, 
urea = 46 mg/dL, creatinine = 1.1 mg/dL, cerebrospinal fluid: 
cells = 40.6, lymphocytes (99%), red blood cells = 53.3, 
glucose = 77 mg/dL, and proteins = 87 mg/dL.
Various blood culture samples were collected for fungal 
search, and results were negative throughout the patient’s 
hospital stay. A search for fungi in the cerebrospinal fluid 
was performed by counter-immunoelectrophoresis, with 
negative results for paracoccidioidomycosis, histoplasmo-
sis, and candidiasis.
Magnetic resonance imaging (MRI) of the brain revealed 
the presence of right fronto-temporal hyperintensity with 
expansive effects in cortical gyri and extension to the hip-
pocampus. The electroencephalogram (EEG) provided 
evidence of non-convulsive status epilepticus. Herpes en-
cephalitis was suggested and therapy with 700 mg acyclovir 
8/8 h was initiated. The consciousness level of the patient 
deteriorated, the fever did not cease (38.3°C), and the 
patient developed generalized urticariform erythema. The 
patient was admitted to the ICU on March 31 with complex 
partial seizures, and submitted to orotracheal intubation 
and mechanical ventilation under sedation with midazolam. 
Physical examination revealed an agitated, disoriented, 
blushing, hydrated, acyanotic, feverish individual with 
regular general health, respiratory rate = 32 inspirations per 
minute, heart rate = 110 beat per minute, blood pressure = 
170/110 mmHg, presence of a systolic murmur in the mitral 
focus, and pulmonary base crackles. The APACHE II score 
(7) was 19, with a death risk of 21%. On the second day in 
the ICU, the patient developed oliguria (510 mL/24 h), urea 
= 76 mg/dL, creatinine = 4.1 mg/dL. Acute renal failure was 
detected following the use of acyclovir, with indication for 
hemodialysis. The patient had fever, presented pulmonary 
secretion and a chest X-ray revealing opacification in the 
right pulmonary base compatible with the diagnosis of 
ventilator-associated pneumonia. On the third day in the 
ICU, he presented hypotension, which did not improve with 
volume infusion and norepinephrine was started.
A new MRI examination showed an expansive lesion of 
the temporal lobe (hypersignal) with apparent invasion of 
the hypothalamus and the thalamus on the right, and the 
presence of leptomeningeal enhancement surrounding the 
temporal lesion. There were no signs of cerebral edema 
(Figure 1). A direct histopathological examination of the 
biopsy obtained from the right temporal lobe evidenced 
the presence of irregular, round, thick-walled fungi forming 
papillae and elongated structures of irregular diameter, with 
no septa, indicative of zygomycete (Basidiobolus). Treat-
ment with liposomal amphotericin B (2 mg·kg-1·day-1) and 
fluconazole (400 mg/day) was initiated after diagnosis of 
meningoencephalitis by zygomycete (basidiobolomycosis), 
with a successful outcome. Administration of liposomal 
amphotericin B was continued for 21 days, reaching an 
accumulated dose of 2230 mg. After a 24-day stay in the 
ICU, the patient was discharged to the ward in satisfactory 
clinical conditions and 9 days later, he was discharged 
from the hospital. 
An EEG carried out at the outpatient clinic in March 
2009 revealed findings consistent with a post-inflammation 
event, with slight disorganization of the right temporal areas. 
MRI performed on the same date demonstrated areas of 
encephalomalacia in the right temporal lobe and marginal 
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Figure 1. MRI. Lesion showing hypersignal on the fronto-insular-temporal region (white arrows) with apparent contralateral involve-
ment (black arrow), and the presence of leptomeningeal enhancement surrounding the temporal lesion (white arrows) (T1-weighted 
contrast MRI - bottom right). There were no signs of cerebral edema. 
Figure 2. MRI. Focal encephalomalacia in the right temporal lobe (white arrows), without major imaging abnormalities.
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gliosis, without major neurological disorders (Figure 2).
The patient is currently under follow-up and shows 
good overall clinical conditions. Neurological examination 
performed in June 2010 revealed normal levels of con-
sciousness. The mini-mental state examination, the most 
commonly used instrument for screening cognitive impair-
ment, was also carried out and revealed normal cognitive 
function with a final score of 28 points. The patient was also 
submitted to the verbal fluency test (animal category) and 
named 15 animals in 1 min, a result considered normal for 
his schooling level. This test is a kind of psychological test 
in which participants have to say as many words as possible 
from a category in a given time (usually 60 s). This category 
can be semantic, such as animals or fruits, or phonemic, 
such as words that begin with a given letter.
We also performed the clock-drawing test, which 
yielded a total score of 10 points. The clock-drawing test 
is a simple neuropsychometric instrument that can be 
easily applied to assess several cognitive functions. Many 
cortical, subcortical, anterior, posterior, right and left skills 
in brain hemispheres have to operate simultaneously to 
draw a clock, particularly involving the frontal, temporal and 
parietal regions. The test displays a sensitivity of 78% and 
specificity of 96% for a score of 10 points. Additionally, we 
submitted the patient to the evaluation of daily life activities 
using the modified Barthel Index, a scale commonly used to 
measure disability or dependence in activities of daily living. 
The test yielded a total of 100 points, which demonstrated 
that the patient was considered to be fully independent to 
perform his daily activities.
Discussion
Despite the rise in the frequency of zycomycosis over the 
last 10 years (8,9), there are few reports on this infection in 
immunocompetent patients. We report here a severe case 
of zycomycosis caused by fungi of the order Entomophtho-
rales, family Basidiobolaceae and genus Basidiobolus, 
which resulted in meningoencephalitis and septic shock in 
an immunocompetent individual. 
Usually, opportunistic diseases in the ICU setting occur in 
patients with comorbidity due to extremely severe illnesses. 
Diagnosis is slow and hard because of the low efficacy of 
commercially available tests, poor mycology laboratory 
infrastructure, and difficult access to some body organs, 
which in turn hinders biopsy procedures. Death rates are 
high, and there has been an upsurge in mortality during 
the last years. The current clinical scenario of fungal infec-
tions is thus characterized by increasing incidence, difficult 
diagnosis, and high mortality. Consequently, antifungal 
prophylaxis and empirical therapeutics are increasingly 
being employed. Once they are identified, treatment against 
these fungi is usually successful (10). Routine tests normally 
isolate up to zygomycete or to the genus, at most. In the 
most comprehensive review of zygomycosis published to 
date, a high percentage of the 929 cases reviewed lacked 
identification at the species level, and identification was 
dubious in many of them (11). Over the last few years 
it has been demonstrated that DNA sequence analysis, 
especially in the case of ribosomal DNA (rDNA), is useful 
for the identification of zygomycetes (12,13).
Early diagnosis, together with treatment of the underly-
ing disease, surgery and therapy with amphotericin B are 
necessary for a successful outcome. Genera of the order 
Entomophthorales can produce chronic subcutaneous infec-
tion in immunocompetent patients. Infection takes place in 
tropical and subtropical climates. The genus Basidiobolus 
typically leads to subcutaneous infection of the thigh, but-
tock, and/or trunk. Involvement of the gastrointestinal tract 
has rarely been reported. The genus Conidiobolus causes 
chronic infection of the nasal submucosa and subcutaneous 
tissue of the nose and face (14). The diagnosis of zygomy-
cosis is based on clinical examination and is confirmed by 
biopsy, with detection of nonseptate hyphae with right-angle 
branches and tissue invasion (15). 
The hyphae of zygomycetes appear to be thinner-walled 
compared with other fungal hyphae, a fact that possibly ac-
counts for their weaker staining with Gomori methenamine 
silver and periodic acid-Schiff relative to fungi with thicker 
cell walls (16). Culture samples can be used to identify the 
species, although they may not reveal isolation even in the 
presence of disseminated and aggressive disease. 
There is no fast specific laboratory test that enables 
confirmation of invasive fungal disease. Unless the physician 
suspects this condition, the disease may progress rapidly 
while the patient is treated with broad-spectrum antibiotics. 
Differential diagnosis between fungal and bacterial infec-
tion is often difficult. Presentation is sometimes atypical, 
and etiological investigation is not always successful. It is 
important to highlight the role of diagnostic investigation 
through biopsy by bronchoscopy or thoracoscopy, and/or 
biopsy of cutaneous-mucosal or brain lesions. The medical 
staff should not await the final result to initiate fungal therapy. 
Microscopy examination of the tissues is very important 
for diagnosis, mainly to detect the presence of nonseptate 
hyphae, which is an indication of zycomycosis. Culture is 
usually not very sensitive. In approximately 30 to 40% of 
cases, nonseptate hyphae are detected in the samples 
used for tissue biopsy, but culture is negative. Neverthe-
less, one approach to searching for this type of fungus is 
its molecular identification (12,13,17-19). Recently, Alvarez 
et al. (20) identified 190 strains of zygomycetes that had 
been previously classified on the basis of morphology. By 
sequencing the internal transcribed spacer region of the 
rDNA, these investigators demonstrated that Rhizopus 
oryzae corresponded to 44.7% of the fungi identified. In 
agreement with the present study, the predominant clinical 
manifestations were the rhinocerebral (25.8%), pulmonary 
(26.8%), and cutaneous (28%) forms. Alvarez et al. (20) 
concluded that identification of zygomycetes still is a hard 
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and laborious task, and that morphological features alone 
may provide a precise diagnosis if assessed by experienced 
professionals. The case reported here shows that zygomy-
cosis can also affect patients with no history of immuno-
compromising states, and that therefore this disease should 
be considered in patients presenting meningoencephalitis 
of undetermined ethiology. 
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